C. Cirauqui

发表

Downregulation of PPP2R5E is a common event in acute myeloid leukemia that affects the oncogenic potential of leukemic cells

M. Odero, M. Calasanz, Remedios Castelló-Cros, 2013, Haematologica.

Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia

M. Odero, M. Calasanz, I. Cristóbal, 2012, Haematologica.

Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.

P. Reche, F. Cañada, B. Cases, 2016, The Journal of allergy and clinical immunology.

PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect

M. Odero, M. Calasanz, M. Alonso, 2011, Leukemia.

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.

S. Vicent, E. Guruceaga, M. Redrado, 2019, Cancer letters.

FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy

L. Paz-Ares, A. Carnero, S. Molina-Pinelo, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

R. López-López, M. Pajares, D. Hervás, 2019, Scientific Reports.

Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia

M. Odero, M. Calasanz, Remedios Castelló-Cros, 2012, PloS one.

Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia.

M. Odero, E. Imbuluzqueta, Raffaella Pippa, 2015, Journal of biomedical nanotechnology.

MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88

J. Subiza, C. Benito-Villalvilla, C. M. Diez-Rivero, 2016, Mucosal Immunology.

Human dendritic cells activated with MV130 induce Th1, Th17 and IL‐10 responses via RIPK2 and MyD88 signalling pathways

S. Sánchez-Ramón, B. Perez-Villamil, D. Sancho, 2017, European journal of immunology.

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

S. Vicent, F. López-Ríos, L. Paz-Ares, 2020, EBioMedicine.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1.

R. López-López, M. Pajares, D. Hervás, 2019 .

Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1.

P. Reche, F. Cañada, B. Cases, 2016, The Journal of allergy and clinical immunology.